Literature DB >> 22981697

Spinal muscular atrophy at the crossroads of basic science and therapy.

James N Sleigh1, Stuart J Grice, Kay E Davies, Kevin Talbot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22981697     DOI： 10.1016/j.nmd.2012.08.008

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  4 in total

1.  Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.

Authors:  Andreea Mihaela Seferian; Amélie Moraux; Aurélie Canal; Valérie Decostre; Oumar Diebate; Anne Gaëlle Le Moing; Teresa Gidaro; Nicolas Deconinck; Frauke Van Parys; Wendy Vereecke; Sylvia Wittevrongel; Mélanie Annoussamy; Michèle Mayer; Kim Maincent; Jean-Marie Cuisset; Vincent Tiffreau; Severine Denis; Virginie Jousten; Susana Quijano-Roy; Thomas Voit; Jean-Yves Hogrel; Laurent Servais
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 2.  Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.

Authors:  Andrew P Tosolini; James N Sleigh
Journal:  Front Mol Neurosci       Date:  2017-12-07       Impact factor: 5.639

3.  Motor defects in a Drosophila model for spinal muscular atrophy result from SMN depletion during early neurogenesis.

Authors:  Stuart J Grice; Ji-Long Liu
Journal:  PLoS Genet       Date:  2022-07-25       Impact factor: 6.020

4.  Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.

Authors:  James N Sleigh; Stuart J Grice; Robert W Burgess; Kevin Talbot; M Zameel Cader
Journal:  Hum Mol Genet       Date:  2013-12-23       Impact factor: 6.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.